Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 40
Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 121
InSphero Acquires PhenoVista Biosciences to Expand 3D Cell Assay Capabilities
InSphero AG has acquired PhenoVista Biosciences, Inc., a San Diego-based provider of high-content imaging and phenotypic assay services. The deal combines PhenoVista’s expertise in imaging-based assay development and cell painting with InSphero’s leadership in scalable 3D microtissue models and microphysiological systems. Financial terms were not disclosed. PhenoVista Biosciences is a contract research organization (CRO) that develops and executes disease-relevant, cell-based assays for biopharmaceutical clients of all stages and sizes using advanced cell models combined with high-content imaging and sophisticated data-analysis capabilities. Based in Switzerland, InSphero AG is a global... Read More »
Lexitas Pharma Services Acquires Erie Retina Research, CASExERIE and Element Erie
Lexitas Pharma Services, an ophthalmology-focused contract research organization (CRO) and portfolio company of QHP Capital, has acquired Erie Retina Research, CASExERIE, LLC and the assets of Element Erie: Imaging & Reading Center PLLC. Erie Retina Research will operate as a wholly owned subsidiary of Lexitas. As part of the transaction, Dr. David Almeida, MD, MBA, PhD, will join Lexitas as Chief Retina Strategy Officer. Financial terms were not disclosed. Erie Retina Research is a premier vitreoretinal clinical research center in Erie, Pennsylvania, with more than 40 active trials and more than 1,000 patients enrolled since 2019. CASExERIE serves as an ophthalmic innovation hub for... Read More »
Iterative Health Acquires Three Cardiology Research Sites from NextStage Clinical Research
Iterative Health has acquired three cardiology research sites located in Beaumont, Port Arthur and Waco, Texas from NextStage Clinical Research. The sites bring experienced research teams, established community provider relationships, and an active portfolio of cardiovascular trials to Iterative Health’s global site network. Financial terms were not disclosed. The acquired sites join Iterative Health’s network of more than 100 sites across three continents. Iterative Health provides centralized operational support, proprietary AI tools for patient recruitment and trial efficiency and end-to-end services across clinical, regulatory and financial functions. The addition deepens the company’s... Read More »
OrganaBio Acquires Excellos Operating Assets to Create Bicoastal Cell Therapy CDMO
OrganaBio, LLC has acquired substantially all operating assets of San Diego, California-based Excellos Inc., forming a coast-to-coast cell therapy contract development and manufacturing organization (CDMO). The deal creates a newly formed OrganaBio subsidiary, Excellos Labs, LLC, to oversee San Diego operations. The core Excellos team has been retained to ensure seamless continuity for existing customer programs. Financial terms were not disclosed. The combined platform integrates OrganaBio’s East Coast strengths in adult leukapheresis (HemaCenter), birth tissue and cord blood sourcing (GaiaGift), PBMC isolation and cryopreservation with Excellos’ purpose-built San Diego facility featuring... Read More »
Celerion Receives a Majority Investment from THL Partners
Celerion will receive a majority investment from THL Partners, according to an April 22 press release from THL. The investment will support Celerion’s continued growth, expanding its clinical and bioanalytical capabilities and advancing its work to help pharmaceutical and biotechnology partners bring new therapies to patients worldwide. Based in Lincoln, Nebraska, Celerion is a clinical research organization that provides comprehensive clinical trial solutions to pharmaceutical and biotechnology clients conducting early clinical research throughout North America, Europe and Asia. The company was previously acquired by leading global private equity and alternative assets investment... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
